Clinical Trials Browser

Recruiting × Observational × Fulvestrant × Clear all

NCT07347600 2026-05-18

reaINAVO

Breast Neoplasms

NCT06734533 2024-12-16

Anlotinib-based Combination Therapy in Patients with Hormone Receptor-positive（HR+） Metastatic Breast Cancer(MBC) .

HR+ Breast Cancer